The single-use bio reactors market size has grown exponentially in recent years. It will grow from $6.18 billion in 2025 to $7.5 billion in 2026 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing biopharmaceutical research activities, increasing adoption of monoclonal antibody production, expansion of clinical trial pipelines, rising demand for faster bioprocess development, early shift from stainless steel systems.
The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $16.28 billion in 2030 at a compound annual growth rate (CAGR) of 21.4%. The growth in the forecast period can be attributed to increasing investments in biologics manufacturing, rising adoption of continuous bioprocessing, growing demand for vaccine production capacity, expansion of personalized medicine pipelines, increasing focus on cost-efficient biomanufacturing. Major trends in the forecast period include increasing adoption of disposable bioprocessing systems, rising demand for flexible and scalable bioreactors, growing use of single-use systems in bioproduction, expansion of modular biomanufacturing facilities, enhanced focus on contamination risk reduction.
The rising demand for pharmaceutical products is expected to support the growth of the single-use bioreactors market going forward. Pharmaceutical products include scientifically developed drugs and medical formulations intended to diagnose, treat, prevent, or manage diseases and health conditions while meeting established standards of safety, efficacy, and quality. The growing demand for pharmaceutical products is primarily driven by the increasing global disease burden, which is intensifying the need for effective and widely accessible treatments, thereby accelerating drug utilization and overall healthcare consumption. Single-use bioreactors support pharmaceutical manufacturing by enabling rapid, contamination-free, and highly adaptable bioproduction processes that facilitate efficient scale-up and ensure consistent product quality. For example, in November 2024, according to a report released by the Italian Medicines Agency (AIFA), an Italy-based regulatory authority, Italy recorded an average daily consumption of 1,899 medication doses per 1,000 inhabitants in 2023, with 69.7% supplied through the National Health Service and the remaining 30.3% purchased directly by citizens. As a result, the increasing demand for pharmaceutical products is driving the growth of the single-use bioreactors market.
Companies operating in the single-use bioreactor market are increasingly developing technologically advanced solutions, such as X-platform bioreactors, to strengthen their competitive positioning. X-platform bioreactors are engineered to address current and future single-use upstream bioprocessing requirements and operate in conjunction with the Cytiva Bioreactor Scaler to enable optimized scale-up without reliance on trial-and-error approaches. For instance, in April 2023, Cytiva Bioscience Holding Ltd., a US-based life sciences company, launched X-platform bioreactors aimed at improving efficiency in single-use upstream bioprocessing. Initially offered in volumes ranging from 50 to 200 liters, these systems are equipped with Figurate automation software and are designed to enhance process efficiency by increasing production capacity, improving ergonomics, and streamlining supply chain operations.
In June 2023, Donaldson Company Inc., a US-based vertically integrated filtration company, acquired Univercells Technologies for $136 million. Through this acquisition, Donaldson Company Inc. seeks to expand its product portfolio and deliver a broader, differentiated range of solutions as part of its life sciences growth strategy. Univercells Technologies is a Belgium-based biotechnology company specializing in single-use bioprocessing and bioreactor technologies.
Major companies operating in the single-use bio reactors market are Sartorius AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eppendorf AG, ABEC Inc., PBS Biotech Inc., Infors AG, Solaris Biotechnology Srl, Cellexus International Ltd., Getinge AB, Kuhner AG, ZETA Holding GmbH, BBI-Biotech GmbH, Tofflon Science And Technology Group Co Ltd, Bioengineering AG, H.E.L Group Ltd, Electrolab Biotech Ltd, GEA Group AG.
North America was the largest region in the single use bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bio reactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-use bio reactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the single-use bio reactors market by increasing costs of imported polymer films, sensors, connectors, control systems, and precision manufacturing equipment used in disposable bioreactor assemblies. Biopharmaceutical manufacturers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces higher costs in scale-up facilities. These tariffs are increasing operational costs and procurement timelines. However, they are also encouraging localized production of single-use components, regional supply chain diversification, and domestic manufacturing investments to strengthen long-term bioprocessing resilience.
The single-use bio reactors market research report is one of a series of new reports that provides single-use bio reactors market statistics, including single-use bio reactors industry global market size, regional shares, competitors with a single-use bio reactors market share, detailed single-use bio reactors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bio reactors industry. This single-use bio reactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A single-use bioreactor is a type of bioreactor that features a disposable bag instead of a traditional culture vessel. These bioreactors enable processors to utilize disposable technologies, including single-use bags, in steps that were traditionally reserved for stainless steel equipment.
The primary types of single-use bioreactors include stirred-tank SUBs (Single-Use Bioreactors), wave-induced SUBs, bubble-column SUBs, and other variations. Stirred-tank bioreactor designs, mimicking the functionality of traditional stirred-tank bioreactors, have gained increased market adoption. These bioreactors are employed in the production of various molecules such as vaccines, monoclonal antibodies, stem cells, and recombinant proteins, involving different cell types like mammalian cells, bacteria, and yeast. The applications of single-use bioreactors encompass research and development, process development, and bioproduction. End-users of these bioreactors include pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), academic and research institutes, as well as contract manufacturing organizations (CMOs).
The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $16.28 billion in 2030 at a compound annual growth rate (CAGR) of 21.4%. The growth in the forecast period can be attributed to increasing investments in biologics manufacturing, rising adoption of continuous bioprocessing, growing demand for vaccine production capacity, expansion of personalized medicine pipelines, increasing focus on cost-efficient biomanufacturing. Major trends in the forecast period include increasing adoption of disposable bioprocessing systems, rising demand for flexible and scalable bioreactors, growing use of single-use systems in bioproduction, expansion of modular biomanufacturing facilities, enhanced focus on contamination risk reduction.
The rising demand for pharmaceutical products is expected to support the growth of the single-use bioreactors market going forward. Pharmaceutical products include scientifically developed drugs and medical formulations intended to diagnose, treat, prevent, or manage diseases and health conditions while meeting established standards of safety, efficacy, and quality. The growing demand for pharmaceutical products is primarily driven by the increasing global disease burden, which is intensifying the need for effective and widely accessible treatments, thereby accelerating drug utilization and overall healthcare consumption. Single-use bioreactors support pharmaceutical manufacturing by enabling rapid, contamination-free, and highly adaptable bioproduction processes that facilitate efficient scale-up and ensure consistent product quality. For example, in November 2024, according to a report released by the Italian Medicines Agency (AIFA), an Italy-based regulatory authority, Italy recorded an average daily consumption of 1,899 medication doses per 1,000 inhabitants in 2023, with 69.7% supplied through the National Health Service and the remaining 30.3% purchased directly by citizens. As a result, the increasing demand for pharmaceutical products is driving the growth of the single-use bioreactors market.
Companies operating in the single-use bioreactor market are increasingly developing technologically advanced solutions, such as X-platform bioreactors, to strengthen their competitive positioning. X-platform bioreactors are engineered to address current and future single-use upstream bioprocessing requirements and operate in conjunction with the Cytiva Bioreactor Scaler to enable optimized scale-up without reliance on trial-and-error approaches. For instance, in April 2023, Cytiva Bioscience Holding Ltd., a US-based life sciences company, launched X-platform bioreactors aimed at improving efficiency in single-use upstream bioprocessing. Initially offered in volumes ranging from 50 to 200 liters, these systems are equipped with Figurate automation software and are designed to enhance process efficiency by increasing production capacity, improving ergonomics, and streamlining supply chain operations.
In June 2023, Donaldson Company Inc., a US-based vertically integrated filtration company, acquired Univercells Technologies for $136 million. Through this acquisition, Donaldson Company Inc. seeks to expand its product portfolio and deliver a broader, differentiated range of solutions as part of its life sciences growth strategy. Univercells Technologies is a Belgium-based biotechnology company specializing in single-use bioprocessing and bioreactor technologies.
Major companies operating in the single-use bio reactors market are Sartorius AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eppendorf AG, ABEC Inc., PBS Biotech Inc., Infors AG, Solaris Biotechnology Srl, Cellexus International Ltd., Getinge AB, Kuhner AG, ZETA Holding GmbH, BBI-Biotech GmbH, Tofflon Science And Technology Group Co Ltd, Bioengineering AG, H.E.L Group Ltd, Electrolab Biotech Ltd, GEA Group AG.
North America was the largest region in the single use bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bio reactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the single-use bio reactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the single-use bio reactors market by increasing costs of imported polymer films, sensors, connectors, control systems, and precision manufacturing equipment used in disposable bioreactor assemblies. Biopharmaceutical manufacturers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces higher costs in scale-up facilities. These tariffs are increasing operational costs and procurement timelines. However, they are also encouraging localized production of single-use components, regional supply chain diversification, and domestic manufacturing investments to strengthen long-term bioprocessing resilience.
The single-use bio reactors market research report is one of a series of new reports that provides single-use bio reactors market statistics, including single-use bio reactors industry global market size, regional shares, competitors with a single-use bio reactors market share, detailed single-use bio reactors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bio reactors industry. This single-use bio reactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A single-use bioreactor is a type of bioreactor that features a disposable bag instead of a traditional culture vessel. These bioreactors enable processors to utilize disposable technologies, including single-use bags, in steps that were traditionally reserved for stainless steel equipment.
The primary types of single-use bioreactors include stirred-tank SUBs (Single-Use Bioreactors), wave-induced SUBs, bubble-column SUBs, and other variations. Stirred-tank bioreactor designs, mimicking the functionality of traditional stirred-tank bioreactors, have gained increased market adoption. These bioreactors are employed in the production of various molecules such as vaccines, monoclonal antibodies, stem cells, and recombinant proteins, involving different cell types like mammalian cells, bacteria, and yeast. The applications of single-use bioreactors encompass research and development, process development, and bioproduction. End-users of these bioreactors include pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), academic and research institutes, as well as contract manufacturing organizations (CMOs).
The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Single-Use Bio Reactors Market Characteristics
3. Single-Use Bio Reactors Market Supply Chain Analysis
4. Global Single-Use Bio Reactors Market Trends and Strategies
5. Single-Use Bio Reactors Market Analysis of End Use Industries
7. Global Single-Use Bio Reactors Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Single-Use Bio Reactors Total Addressable Market (TAM) Analysis for the Market
9. Single-Use Bio Reactors Market Segmentation
10. Single-Use Bio Reactors Market Regional and Country Analysis
11. Asia-Pacific Single-Use Bio Reactors Market
12. China Single-Use Bio Reactors Market
13. India Single-Use Bio Reactors Market
14. Japan Single-Use Bio Reactors Market
15. Australia Single-Use Bio Reactors Market
16. Indonesia Single-Use Bio Reactors Market
17. South Korea Single-Use Bio Reactors Market
18. Taiwan Single-Use Bio Reactors Market
19. South East Asia Single-Use Bio Reactors Market
20. Western Europe Single-Use Bio Reactors Market
21. UK Single-Use Bio Reactors Market
22. Germany Single-Use Bio Reactors Market
23. France Single-Use Bio Reactors Market
24. Italy Single-Use Bio Reactors Market
25. Spain Single-Use Bio Reactors Market
26. Eastern Europe Single-Use Bio Reactors Market
27. Russia Single-Use Bio Reactors Market
28. North America Single-Use Bio Reactors Market
29. USA Single-Use Bio Reactors Market
30. Canada Single-Use Bio Reactors Market
31. South America Single-Use Bio Reactors Market
32. Brazil Single-Use Bio Reactors Market
33. Middle East Single-Use Bio Reactors Market
34. Africa Single-Use Bio Reactors Market
36. Single-Use Bio Reactors Market Competitive Landscape and Company Profiles
37. Single-Use Bio Reactors Market Other Major and Innovative Companies
40. Single-Use Bio Reactors Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Single-Use Bio Reactors Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses single-use bio reactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for single-use bio reactors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-use bio reactors market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Stirred-Tank SUBs; Wave-Induced SUBs; Bubble-Column SUBs2) By Molecule Type: Vaccines; Monoclonal Antibodies; Stem Cells; Recombinant Proteins
3) By Cell Type: Mammalian Cell; Bacteria; Yeast
4) By Application: Research And Development (R&D); Process Development; Bioproduction
5) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Research Organizations (CRO); Academic And Research Institutes; Contract Manufacturing Organizations (CMO)
Subsegments:
1) By Stirred-Tank SUBs: Single-Use Stirred-Tank Bioreactors; Batch Stirred-Tank SUBs; Continuous Stirred-Tank SUBs2) By Wave-Induced SUBs: Wave-Mixed Bioreactors; Disposable Wave Bioreactors
3) By Bubble-Column SUBs: Aerated Bubble-Column SUBs; Non-Aerated Bubble-Column SUBs
Companies Mentioned: Sartorius AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE HealthCare Technologies Inc.; Eppendorf AG; ABEC Inc.; PBS Biotech Inc.; Infors AG; Solaris Biotechnology Srl; Cellexus International Ltd.; Getinge AB; Kuhner AG; ZETA Holding GmbH; BBI-Biotech GmbH; Tofflon Science And Technology Group Co Ltd; Bioengineering AG; H.E.L Group Ltd; Electrolab Biotech Ltd; GEA Group AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Single-Use Bio Reactors market report include:- Sartorius AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Merck KGaA
- GE HealthCare Technologies Inc.
- Eppendorf AG
- ABEC Inc.
- PBS Biotech Inc.
- Infors AG
- Solaris Biotechnology Srl
- Cellexus International Ltd.
- Getinge AB
- Kuhner AG
- ZETA Holding GmbH
- BBI-Biotech GmbH
- Tofflon Science And Technology Group Co Ltd
- Bioengineering AG
- H.E.L Group Ltd
- Electrolab Biotech Ltd
- GEA Group AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.5 Billion |
| Forecasted Market Value ( USD | $ 16.28 Billion |
| Compound Annual Growth Rate | 21.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
